CI
Cigna Corporation NYSE$282.90
Mkt Cap $75.2B
52w Low $239.51
39.3% of range
52w High $350.00
50d MA $274.70
200d MA $282.32
P/E (TTM)
12.7x
EV/EBITDA
8.4x
P/B
1.8x
Debt/Equity
0.8x
ROE
14.3%
P/FCF
8.7x
RSI (14)
—
ATR (14)
—
Beta
0.27
50d MA
$274.70
200d MA
$282.32
Avg Volume
1.7M
About
The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment o…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | TNS | 7.60 | 7.79 | +2.5% | 290.58 | -0.5% | -2.6% | — | — | — | — | — | — |
| Feb 5, 2026 | TNS | 7.88 | 8.08 | +2.5% | 284.53 | -0.3% | +2.6% | +3.5% | +1.2% | +3.6% | +1.1% | -5.2% | — |
| Oct 30, 2025 | TNS | 7.64 | 7.83 | +2.5% | 247.10 | +0.4% | -1.1% | +4.7% | +7.1% | +5.1% | +3.8% | +10.7% | — |
| Jul 31, 2025 | TNS | 7.16 | 7.20 | +0.6% | 267.38 | +0.8% | -1.9% | -0.3% | +1.3% | +1.0% | +1.4% | +12.5% | — |
| May 2, 2025 | TNS | 6.35 | 6.74 | +6.1% | 334.75 | +0.7% | -0.5% | -0.3% | -0.1% | -0.5% | -0.4% | -5.9% | — |
| Jan 30, 2025 | TNS | 7.84 | 6.64 | -15.3% | 282.98 | +0.6% | +4.0% | +3.4% | +3.0% | +3.7% | +1.5% | +10.1% | — |
| Oct 31, 2024 | TNS | 7.23 | 7.51 | +3.9% | 314.81 | -0.5% | +0.5% | -0.8% | +1.1% | +0.1% | +1.5% | +7.1% | — |
| Aug 1, 2024 | TNS | 6.41 | 6.72 | +4.8% | 332.60 | +0.2% | +1.4% | -2.1% | -1.0% | -1.1% | +0.7% | +9.9% | — |
| May 2, 2024 | TNS | 6.22 | 6.47 | +4.0% | 344.50 | -0.6% | -0.9% | -0.6% | +0.6% | +0.8% | +1.9% | -0.9% | — |
| Feb 2, 2024 | TNS | 6.54 | 6.79 | +3.8% | 323.84 | +1.1% | -0.8% | +1.2% | +2.1% | +2.6% | +3.4% | +4.0% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Barclays | Maintains | Overweight → Overweight | — | $290.58 | $289.08 | -0.5% | -2.6% | — | — | — | — |
| May 1 | RBC Capital | Maintains | Outperform → Outperform | — | $290.58 | $289.08 | -0.5% | -2.6% | — | — | — | — |
| May 1 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $290.58 | $289.08 | -0.5% | -2.6% | — | — | — | — |
| May 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $290.58 | $289.08 | -0.5% | -2.6% | — | — | — | — |
| Apr 20 | Jefferies | Maintains | Buy → Buy | — | $278.64 | $279.78 | +0.4% | +0.5% | -0.7% | -1.4% | +0.4% | -1.1% |
| Mar 12 | Bernstein | Upgrade | Market Perform → Outperform | — | $260.87 | $263.28 | +0.9% | +1.9% | +2.4% | +2.9% | +1.0% | +1.4% |
| Mar 3 | Piper Sandler | Maintains | Overweight → Overweight | — | $290.85 | $283.00 | -2.7% | -2.4% | -2.1% | -3.3% | -6.6% | -7.3% |
| Feb 17 | Truist | Maintains | Buy → Buy | — | $291.44 | $294.43 | +1.0% | -0.3% | -0.5% | -1.9% | -3.8% | -2.8% |
| Feb 9 | TD Cowen | Maintains | Buy → Buy | — | $292.05 | $295.00 | +1.0% | +0.8% | -1.5% | +0.9% | -1.5% | -0.2% |
| Feb 6 | RBC Capital | Maintains | Outperform → Outperform | — | $284.53 | $283.72 | -0.3% | +2.6% | +3.5% | +1.2% | +3.6% | +1.1% |
Recent Filings
8-K
Cigna Corporation -- 8-K Filing
Cigna's leadership emphasizes strategic focus on healthcare innovation and digital transformation to enhance customer experience and operational efficiency across its insurance portfolio.
Apr 30
8-K
The Cigna Group -- 8-K Filing
Cigna Group shareholders will vote on an advisory measure regarding executive compensation practices, a non-binding referendum on management's pay structure.
Apr 27
8-K · 5.02
!!! Very High
The Cigna Group -- 8-K 5.02: Executive Change
Cigna Group appoints Brian C. Evanko as Chief Executive Officer effective July 1, 2026, signaling planned leadership transition and potential strategic direction change for the healthcare company.
Mar 3
8-K · 7.01
! Medium
The Cigna Group -- 8-K 7.01: Regulation FD Disclosure
Cigna Group reaffirmed its 2026 guidance of at least $30.25 adjusted earnings per share, signaling management confidence in achieving previously communicated financial targets.
Feb 27
8-K
The Cigna Group -- 8-K Filing
Cigna Group's 2025 initiatives focusing on expanded access, cost reduction, and transparency demonstrate management's commitment to improving customer value and operational efficiency.
Feb 5
Data updated apr 25, 2026 1:21am
· Source: massive.com